Linked Life Data

12187895

Source:http://linkedlifedata.com/resource/pubmed/id/12187895

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-8-21
pubmed:abstractText
Antiarrhythmic drugs in atrial fibrillation are relatively old and have well-specified indications. Class I antiarrhythmic drugs (IA: quinidine, disopyramide; IC: cibenzoline, flecainide, propafenone) are first indicated in patients without history of myocardial infarction and heart failure. In this last case, a b-blocker or amiodarone are indicated. Amiodarone is also indicated after failure of class I antiarrhythmic drugs. The association of class I antiarrhythmic drugs or amiodarone with a small dose of b-blocker is suitable if possible. However, the association of amiodarone with half-dose of a class I antiarrhythmic drug should remain rare, because the prognosis of chronic atrial fibrillation is unknown; the benefits to risks ratio of antiarrhythmic treatment should be discussed for each patient.
pubmed:commentsCorrections
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0035-2640
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1317-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Antiarrhythmic drugs in atrial fibrillation].
pubmed:affiliation
Service de cardiologie Hôpital d'adultes de Brabois 54511 Vandoeuvre-lès-Nancy. b.brembilla-perrot@chu-nancy.fr
pubmed:publicationType
Journal Article, English Abstract, Review